|
1
|
Roles for c-Myc in self-renewal of hematopoietic stem cells.
|
J Biol Chem
|
2004
|
1.95
|
|
2
|
The scaffolding adapter Gab2, via Shp-2, regulates kit-evoked mast cell proliferation by activating the Rac/JNK pathway.
|
J Biol Chem
|
2006
|
1.27
|
|
3
|
Critical roles of c-Kit tyrosine residues 567 and 719 in stem cell factor-induced chemotaxis: contribution of src family kinase and PI3-kinase on calcium mobilization and cell migration.
|
Blood
|
2002
|
1.18
|
|
4
|
Notch signals inhibit the development of erythroid/megakaryocytic cells by suppressing GATA-1 activity through the induction of HES1.
|
J Biol Chem
|
2004
|
1.15
|
|
5
|
Functional cooperation among Ras, STAT5, and phosphatidylinositol 3-kinase is required for full oncogenic activities of BCR/ABL in K562 cells.
|
J Biol Chem
|
2002
|
1.04
|
|
6
|
AML1/RUNX1 works as a negative regulator of c-Mpl in hematopoietic stem cells.
|
J Biol Chem
|
2008
|
0.97
|
|
7
|
Roles for deregulated receptor tyrosine kinases and their downstream signaling molecules in hematologic malignancies.
|
Cancer Sci
|
2008
|
0.96
|
|
8
|
GATA transcription factors inhibit cytokine-dependent growth and survival of a hematopoietic cell line through the inhibition of STAT3 activity.
|
J Biol Chem
|
2005
|
0.92
|
|
9
|
Enhanced production of osteopontin in multiple myeloma: clinical and pathogenic implications.
|
Br J Haematol
|
2003
|
0.89
|
|
10
|
Risk factors for cytarabine-induced cutaneous toxicity in patients with haematological malignancies.
|
Chemotherapy
|
2015
|
0.88
|
|
11
|
Distinct role for c-kit receptor tyrosine kinase and SgIGSF adhesion molecule in attachment of mast cells to fibroblasts.
|
Lab Invest
|
2005
|
0.87
|
|
12
|
Roles of tyrosine residues 845, 892 and 922 in constitutive activation of murine FLT3 kinase domain mutant.
|
Oncogene
|
2005
|
0.84
|
|
13
|
Necessity of tyrosine 719 and phosphatidylinositol 3'-kinase-mediated signal pathway in constitutive activation and oncogenic potential of c-kit receptor tyrosine kinase with the Asp814Val mutation.
|
Blood
|
2002
|
0.83
|
|
14
|
Establishment and characterization of unique cell lines derived from pyothorax-associated lymphoma which develops in long-standing pyothorax and is strongly associated with Epstein-Barr virus infection.
|
Cancer Sci
|
2003
|
0.81
|
|
15
|
Endolymphatic hydrops as a cause of audio-vestibular manifestations in relapsing polychondritis.
|
Acta Otolaryngol
|
2006
|
0.80
|
|
16
|
Constitutive activation of c-kit by the juxtamembrane but not the catalytic domain mutations is inhibited selectively by tyrosine kinase inhibitors STI571 and AG1296.
|
Int J Hematol
|
2002
|
0.80
|
|
17
|
Managing hepatitis B virus carriers with systemic chemotherapy or biologic therapy in the outpatient clinic.
|
Hepatol Res
|
2012
|
0.79
|
|
18
|
Constitutively activated Rho guanosine triphosphatases regulate the growth and morphology of hairy cell leukemia cells.
|
Int J Hematol
|
2003
|
0.79
|
|
19
|
Intravascular lymphomatosis initially suspected from uterine cytology: a case report.
|
Acta Cytol
|
2009
|
0.78
|
|
20
|
Constitutively active FGFR3 with Lys650Glu mutation enhances bortezomib sensitivity in plasma cell malignancy.
|
Anticancer Res
|
2011
|
0.75
|
|
21
|
[Trial of "Huber Plus" in outpatients with chemotherapy by blood port system].
|
Gan To Kagaku Ryoho
|
2008
|
0.75
|
|
22
|
[A case of chronic active Epstein-Barr virus infection associated with recurrent cerebellar ataxia and skin eruptions].
|
Rinsho Shinkeigaku
|
2013
|
0.75
|
|
23
|
Footwear exchange has no influence on the incidence of febrile neutropenia in patients undergoing chemotherapy for hematologic malignancies.
|
Infect Control Hosp Epidemiol
|
2004
|
0.75
|
|
24
|
[Present situation and problems of the ordering system type infusion center].
|
Gan To Kagaku Ryoho
|
2007
|
0.75
|
|
25
|
[Inhibition of leukemogenic signaling and its therapeutic implications].
|
Rinsho Ketsueki
|
2002
|
0.75
|
|
26
|
[Incident surveillance in outpatients treated with hepatic arterial infusion (HAI) chemotherapy with infusion pump].
|
Gan To Kagaku Ryoho
|
2007
|
0.75
|
|
27
|
[The development history and future perspective of molecularly targeted therapy].
|
Nihon Rinsho
|
2014
|
0.75
|
|
28
|
[Our experience using "Huber Plus" needles in our infusion center].
|
Gan To Kagaku Ryoho
|
2008
|
0.75
|
|
29
|
Myeloid neoplasm-related gene abnormalities differentially affect dendritic cell differentiation from murine hematopoietic stem/progenitor cells.
|
Immunol Lett
|
2011
|
0.75
|
|
30
|
An indolent subtype of "intravascular lymphoma": A case with a 3-year history of LDH elevation.
|
Leuk Lymphoma
|
2007
|
0.75
|
|
31
|
[Effect of the administration of zoledronic acid on life expectancy in patients with multiple myeloma with or without renal impairment].
|
Gan To Kagaku Ryoho
|
2014
|
0.75
|